{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to obtaining insights on the prevalence and treatment landscape of bipolar disorder in Indian patients and role of quetiapine in bipolar disorder

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

{{--
--}} @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire
  1. How many patients of bipolar patients do you see in a month? *

  2. What type of bipolar disorder is most common in your practice? *

  3. What is the average age of onset in your bipolar patients? *

  4. What are the top 3 presenting symptoms of bipolar disorder you frequently encounter? *
  5. What percentage of your bipolar patients are newly diagnosed each year? *

  6. What is the average delay in diagnosis after symptom onset? *

  7. Do you use any standardized scales for diagnosis (e.g., DSM-5, ICD-11)? *

  8. What are the most common misdiagnoses before arriving at bipolar disorder? *

  9. What is the key diagnostic challenge(s) you face in bipolar disorder? *
  10. What is the first-line pharmacologic treatment for bipolar depression in your practice? *

  11. What is the first-line pharmacologic treatment for mania/hypomania? *

  12. What is the average treatment duration before evaluating effectiveness? *

  13. Do you routinely use combination therapy in bipolar disorder? *

  14. How do you typically differentiate between bipolar I and bipolar II disorder in your practice? *
  15. How is the usage of long-acting injectables (LAIs) in bipolar disorder in your practice? *

  16. Where do you see higher relapse rates, in your practice? *

  17. What are the most common adverse effects reported by your patients?*

  18. What is the frequency of suicidal ideation in your bipolar patients (per year)? *

  19. Do you modify treatment strategy in presence of comorbidities like diabetes or metabolic syndrome? *

  20. Do you prescribe quetiapine for bipolar disorder? *

  21. Which indications is quetiapine most prescribed for? *

  22. What is the quetiapine dose range typically used for bipolar depression, in your practice? *

  23. What is the quetiapine dose range typically used for mania, in your practice? *

  24. What is the average time to clinical response with quetiapine (in your experience)? *

  25. What are the advantages of quetiapine in bipolar treatment? (Select whichever apply) *

  26. What are the main concerns with quetiapine, in your practice? (Select whichever apply) *

  27. How frequently do you use quetiapine as monotherapy in bipolar depression? *

  28. In your experience, how does quetiapine compare to olanzapine in terms of metabolic side effects? *

  29. In your opinion, what patient profile is best suited for quetiapine therapy in your practice? *
  30. What is the average duration for which you continue quetiapine in bipolar maintenance therapy? *

  31. How does quetiapine perform in patients with rapid cycling bipolar disorder? *

  32. In your experience, how does quetiapine impact the quality of life and functional outcomes in patients with bipolar disorder? *
  33. Which are frequently prescribed strengths for Quetiapine in your practice? *
    34. SKUs %
    %
    {{-- --}}
    %
    {{-- --}}
    %
    {{-- --}}
    %
    {{-- --}}
    %
    {{-- --}}
    %
    {{-- --}}
    %
    {{-- --}}
  34. What % of patients you add quetiapine as add-on to lithium & Divalproex? *
    35. Drugs %
    %
    %
  35. What factors influence your decision to use quetiapine as monotherapy versus in combination with other agents for bipolar disorder? *
  36. Do you actively monitor lipid profile and blood sugar in patients on quetiapine? *

  37. Do you adjust the quetiapine dose based on response or adverse events? *

  38. In your opinion, what kind of real-world data would help establish the value of quetiapine in Indian practice for bipolar disorder management? *
  39. Are there any emerging treatments or research areas that you find particularly promising for patients with bipolar disorder? *
  40. In your practice of bipolar disorder, kindly share percentage frequency of new treatments for below antipsychotics. *
    41. Drugs % Drugs %
    %
    %
    %
    %
    %
    %
  41. Based on your day-to-day practice, kindly share your experience of using Quetiapine in different spectrum of bipolar disorders. *
    42. Very effective Moderately effective Not effective Don’t Use
  42. From your perspective, what role does quetiapine play in the broader treatment algorithm for bipolar disorder in India today? *
  43. What is your clinical approach when a patient on quetiapine experiences a relapse of bipolar symptoms? *